Patents by Inventor Gerd-Ulfert Heese

Gerd-Ulfert Heese has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
    Patent number: 7276253
    Abstract: The invention relates to a stable medicament for oral administration which comprises (a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole, together with customary pharmaceutical adjuvants, (b) an intermediate layer applied onto the core, and (c) a gastric juice-resistant outer layer. The intermediate layer in (b) is formed as a reactive layer in which a gastric juice-resistant polymer layer material partially neutralized with alkali with cation exchange capacity is present. Further, a method for the production of the stable medicament is disclosed.
    Type: Grant
    Filed: August 11, 2006
    Date of Patent: October 2, 2007
    Assignee: AstraZeneca AB
    Inventors: Gerd-Ulfert Heese, Herbert Jünger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss
  • Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
    Publication number: 20070048380
    Abstract: The invention relates to a stable medicament for oral administration which comprises (a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole, together with customary pharmaceutical adjuvants, (b) an intermediate layer applied onto the core, and (c) a gastric juice-resistant outer layer. The intermediate layer in (b) is formed as a reactive layer in which a gastric juice-resistant polymer layer material partially neutralized with alkali with cation exchange capacity is present. Further, a method for the production of the stable medicament is disclosed.
    Type: Application
    Filed: August 11, 2006
    Publication date: March 1, 2007
    Inventors: Gerd-Ulfert Heese, Herbert Junger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss
  • Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
    Publication number: 20050064035
    Abstract: The invention relates to a stable medicament for oral administration which comprises (a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole, together with customary pharmaceutical adjuvants, (b) an intermediate layer applied onto the core, and (c) a gastric juice-resistant outer layer. The intermediate layer in (b) is formed as a reactive layer in which a gastric juice-resistant polymer layer material partially neutralized with alkali with cation exchange capacity is present. Further, a method for the production of the stable medicament is disclosed.
    Type: Application
    Filed: September 16, 2003
    Publication date: March 24, 2005
    Inventors: Gerd-Ulfert Heese, Herbert Junger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss
  • Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
    Patent number: 6623759
    Abstract: The invention relates to a stable medicament for oral administration which comprises (a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole, together with customary pharmaceutical adjuvants, (b) an intermediate layer applied onto the core, and (c) a gastric juice-resistant outer layer. The intermediate layer in (b) is formed as a reactive layer in which a gastric juice-resistant polymer layer material partially neutralized with alkali with cation exchange capacity is present. Further, a method for the production of the stable medicament is disclosed.
    Type: Grant
    Filed: September 5, 2001
    Date of Patent: September 23, 2003
    Assignee: AstraZeneca AB
    Inventors: Gerd-Ulfert Heese, Herbert Jünger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss
  • Stable drug from for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
    Publication number: 20020054913
    Abstract: The invention relates to a stable medicament for oral administration which comprises
    Type: Application
    Filed: September 5, 2001
    Publication date: May 9, 2002
    Inventors: Gerd-Ulfert Heese, Herbert Junger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss
  • Production of pharmaceutical formulations for treatment of edema and venous disorders
    Patent number: 6077534
    Abstract: The invention relates to a medicament containing a standardized dry extract of horse chestnut seeds which is active against various types of edema and diseases of the venous circulatory system and to a process for manufacturing this medicament. The dry seed extract is processed to the form of pellets which can be coated to obtain sustained release of the agent. In this way satisfying therapeutical blood levels of the triterpene glycosides as agent are achieved. The finished medicament according to the invention can best be provided as hard gelatin capsule or matrix tablet containing the extract pellets.
    Type: Grant
    Filed: September 2, 1997
    Date of Patent: June 20, 2000
    Assignee: Klinge Pharma GmbH
    Inventors: James Tobin, Gerd Ulfert Heese